Are you a new member? Sign up now
Login area
| Sign up
close
OPDIVO - 40mg/4ml - 1 x 4ml
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FF01 | BioTech | Nivolumab - 40mg/4ml | 8332 | 120615/1 | OPDIVO | 40mg/4ml | 1 x 4ml | Injectable solution | Infusion | Pacific pharma | Bristol-Myers Squibb Holdings Pharma Ltd Liability Company Manati | USA | 51,234,726 L.L | 10.71 | E1 | Bristol-Myers Squibb Company | USA | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FF01 | BioTech | Nivolumab - 40mg/4ml | 8332/388 | 120615/1 | OPDIVO | 40mg/4ml | 1 x 4ml | Injectable solution | Infusion | Pacific pharma | Bristol-Myers Squibb Holdings Pharma Ltd Liability Company Manati | USA | L.L | 10.71 | E1 | Bristol-Myers Squibb Company | USA | 2/5/2024 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024